RNA biomarkers shed light on osteoarthritis

In research presented at the Orthopaedic Research Society 2012 annual meeting, two biomarkers have come to light that might help in the development of disease-modifying treatments for osteoarthritis, a painful joint condition that is a result of wear and tear on the cartilage. Researchers at Henry Ford Hospital in Detroit have linked the two biomarkers, short stretches of genetic material known as non-coding RNAs, with mild cartilage damage. Gary Gibson, director of Henry Ford's Bone and Joint Center and the study's lead author, said the results might suggest the discovery of a long-awaited biomarker for osteoarthritis, a leading cause of disability. The next step is to find out whether the concentration of the biomarkers can be linked with worsening cartilage damage. Press release

Suggested Articles

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.